Peptide Graded

Bivalirudin

Is Bivalirudin legal in the US?

Yes, FDA approved for use during stenting and angioplasty.

AStrong human evidenceFDA approvedas of 2026-10-26

Bivalirudin is FDA-approved and sold as Angiomax and generics, given intravenously as an anticoagulant during percutaneous coronary intervention (angioplasty and stenting), including in patients with heparin-induced thrombocytopenia. It was first approved in December 2000. 14

Yes. Angiomax won approval in 2000. It is a blood thinner for patients having a coronary stent or balloon procedure. That includes patients who had a bad reaction to heparin. Generic versions are available. 14

Read the full Bivalirudin page

More on Bivalirudin

Citations

  1. Drugs.com monograph: bivalirudin drugs.com
  2. Moen 2005, Drugs: bivalirudin, a review of its use in patients undergoing percutaneous coronary intervention link.springer.com
  3. Stone 2008, NEJM: bivalirudin during primary PCI in acute myocardial infarction (HORIZONS-AMI) doi.org
  4. FDA Drugs@FDA: Angiomax (bivalirudin) NDA 020873 accessdata.fda.gov

Reference information only, not medical advice. Drawn from the Bivalirudin article, fact-checked against the cited sources. No dosing anywhere on this site.